N-desmethyl Regorafenib N-oxide |
| Catalog No.GC49686 |
An active metabolite of regorafenib
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 835621-12-0
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
N-desmethyl Regorafenib N-oxide is an active metabolite of the multi-kinase inhibitor regorafenib .1 It is formed from regorafenib by the cytochrome P450 (CYP) isoform CYP3A4. N-desmethyl Regorafenib N-oxide inhibits VEGFR2, Tie2, c-Kit, and B-RAF in vitro, as well as inhibits tumor growth in HT-29 and MDA-MB-231 mouse xenograft models when administered at a dose of 1 mg/kg.2
1.Li, Y.-H., Lin, Q.-M., Pang, N.-H., et al.Functional characterization of 27 CYP3A4 protein variants to metabolize regorafenib in vitroBasic Clin. Pharmacol. Toxicol.125(4)337-344(2019) 2.Zopf, D., Heinig, R., Thierauch, K.-H., et al.Abstract 1666: Regorafenib (BAY 73-4506): Preclinical pharmacology and clinical identification and quantification of its major metabolitesCancer. Res.70(8 Suppl.)(2010)
Average Rating: 5 (Based on Reviews and 39 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *